Form 4: Lam Research Director Plans $7.9M Stock Sale

Lam Research Director Eric Brandt filed a Form 4 disclosing a pre-planned sale of 35,000 shares of common stock totaling approximately $7.9 million, scheduled for February 6, 2026, under a Rule 10b5-1 plan.

Summary

• Eric Brandt, a Director at Lam Research Corp (LRCX), filed a Form 4 with the SEC.
• The filing discloses a planned sale of 35,000 shares of Lam Research common stock.
• These sales are scheduled to occur on February 6, 2026.
• The transactions are pursuant to a Rule 10b5-1(c) plan, indicating they are pre-scheduled and not based on new material non-public information.
• The planned sales involve two tranches: 17,000 shares at a price of $220.95 per share and 18,000 shares at a price of $230 per share.
• The total aggregate value of the planned sales is approximately $7,896,150.
• Following these planned transactions, Brandt's direct beneficial ownership in Lam Research will be 253,705 shares, which includes shares subject to unvested restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event because the planned sale is conducted under a Rule 10b5-1 plan, indicating a pre-scheduled liquidity event rather than a reaction to new material non-public information, thus not signaling a change in company fundamentals.

Positives

• The transaction is conducted under a Rule 10b5-1 plan, which demonstrates a structured approach to insider liquidity and mitigates concerns about opportunistic selling based on inside information.

Negatives

• The planned sale will result in a reduction of Eric Brandt's direct beneficial ownership in Lam Research by 35,000 shares.

Risks

• While mitigated by the 10b5-1 plan, significant insider selling, even if pre-planned, can sometimes be misinterpreted by the market as a lack of confidence, potentially leading to short-term negative sentiment.

Future Outlook

Not applicable, as this filing reports a specific planned insider transaction and does not provide company-wide forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are closely watched in the semiconductor equipment industry, which is known for its cyclical nature. While a 10b5-1 plan mitigates concerns of opportunistic selling, the market may still consider the overall trend of insider holdings as part of its broader assessment of company health and prospects.

Corporate Governance

Stakeholder Impact

• Shareholders: May observe a slight reduction in insider ownership, but the 10b5-1 plan generally mitigates negative interpretations regarding management's confidence in the company's future.

Next Steps

• The planned sale of 35,000 shares of Lam Research common stock by Eric Brandt is scheduled to occur on February 6, 2026.

Key Dates

Recommendation

While the planned sale by a director reduces insider ownership, the transaction is explicitly under a Rule 10b5-1 plan, suggesting a pre-arranged liquidity event rather than a signal of deteriorating company prospects. Therefore, this filing alone does not warrant a change in investment thesis, leading to a 'hold' recommendation.

Keywords

Lam Research, LRCX, Eric Brandt, Form 4, insider trading, stock sale, 10b5-1 plan, director, semiconductor equipment